FGF23 Reduction : Efficacy of a New Phosphate Binder in CHronic Kidney Disease

NCT01220843 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

98

Enrollment

OTHER

Sponsor class

Conditions

Chronic Renal Failure

Interventions

DRUG: Placebo
DRUG: Sevelamer carbonate

Sponsor

Centre Hospitalier Universitaire, Amiens

Collaborators

[object Object]